Geode Capital Management
WHWK

Geode Capital Management’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$696K Buy
372,334
+136,494
+58% +$255K ﹤0.01% 3449
2025
Q1
$420K Buy
235,840
+18,546
+9% +$33K ﹤0.01% 3610
2024
Q4
$686K Buy
217,294
+8,546
+4% +$27K ﹤0.01% 3499
2024
Q3
$430K Buy
208,748
+2,305
+1% +$4.75K ﹤0.01% 3648
2024
Q2
$301K Sell
206,443
-192,788
-48% -$282K ﹤0.01% 3764
2024
Q1
$934K Buy
399,231
+3,374
+0.9% +$7.9K ﹤0.01% 3388
2023
Q4
$800K Buy
395,857
+29,079
+8% +$58.7K ﹤0.01% 3435
2023
Q3
$1.78M Buy
366,778
+34,265
+10% +$166K ﹤0.01% 3110
2023
Q2
$2.27M Buy
332,513
+60,814
+22% +$416K ﹤0.01% 3070
2023
Q1
$1.97M Buy
271,699
+10,613
+4% +$76.8K ﹤0.01% 3039
2022
Q4
$3.35M Buy
261,086
+4,681
+2% +$60K ﹤0.01% 2860
2022
Q3
$3.62M Sell
256,405
-55,312
-18% -$782K ﹤0.01% 2846
2022
Q2
$3.84M Buy
311,717
+114,533
+58% +$1.41M ﹤0.01% 2837
2022
Q1
$3.35M Buy
197,184
+111
+0.1% +$1.88K ﹤0.01% 3002
2021
Q4
$4.76M Buy
197,073
+168,970
+601% +$4.08M ﹤0.01% 2925
2021
Q3
$825K Sell
28,103
-298,300
-91% -$8.76M ﹤0.01% 3789
2021
Q2
$551K Buy
326,403
+67,429
+26% +$114K ﹤0.01% 3897
2021
Q1
$334K Buy
258,974
+107,136
+71% +$138K ﹤0.01% 3952
2020
Q4
$148K Buy
151,838
+29,595
+24% +$28.8K ﹤0.01% 3973
2020
Q3
$183K Buy
122,243
+7,343
+6% +$11K ﹤0.01% 3745
2020
Q2
$143K Hold
114,900
﹤0.01% 3762
2020
Q1
$63K Hold
114,900
﹤0.01% 3882
2019
Q4
$71K Hold
114,900
﹤0.01% 4032
2019
Q3
$77K Hold
114,900
﹤0.01% 4005
2019
Q2
$104K Hold
114,900
﹤0.01% 3952
2019
Q1
$103K Buy
+114,900
New +$103K ﹤0.01% 3890